Arcellx (ACLX) CFO sells 5,364 shares at $91.0357 under plan
Arcellx (ACLX) reported an insider transaction by its Chief Financial Officer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arcellx (ACLX) reported an insider transaction by its Chief Financial Officer. On 10/15/2025, the CFO sold 5,364 shares of common stock at a weighted average price of $91.0357, with trades ranging from $90.99 to $91.19, under a Rule 10b5-1 trading plan entered on March 21, 2025.
Following the sale, the officer beneficially owns 8,466 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,364 | $91.0357 | $488K |
Footnotes (2)
- F1. The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 21, 2025.
- F2. Represents the weighted average share price of an aggregate total of 5,364 shares sold in the price range of $90.99 to $91.19 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ACLX report?
Was the sale made under a Rule 10b5-1 plan?
What is the officer’s role at Arcellx (ACLX)?
AI-generated analysis. How Rhea-AI works. Not financial advice.